Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pGL410-BRN2p Citations (2)

Originally described in: Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Zeng H, Jorapur A, Shain AH, Lang UE, Torres R, Zhang Y, McNeal AS, Botton T, Lin J, Donne M, Bastian IN, Yu R, North JP, Pincus L, Ruben BS, Joseph NM, Yeh I, Bastian BC, Judson RL Cancer Cell. 2018 Jul 9;34(1):56-68.e9. doi: 10.1016/j.ccell.2018.05.014.
PubMed Journal

Articles Citing pGL410-BRN2p

Articles
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. PubMed
Integrin alpha3beta1 Promotes Invasive and Metastatic Properties of Breast Cancer Cells through Induction of the Brn-2 Transcription Factor. Miskin RP, Warren JSA, Ndoye A, Wu L, Lamar JM, DiPersio CM. Cancers (Basel). 2021 Jan 27;13(3). pii: cancers13030480. doi: 10.3390/cancers13030480. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.